Form4insider filings, from the source

SEC Form 4 · accession 0001562180-17-002413

BIO-TECHNE Corp · TECH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Norman David Eansor
Officer — SVP - Novus Biologicals
Period of report
Jul 1, 2017
Accepted (ET)
Jul 5, 2017 · 5:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJul 1, 2017F534$117.50D3,402D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F2—holding—————Common Stock1,5001,500D
Restricted Stock UnitsF3,F4—holding—————Common Stock2,2872,287D
Stock Option (Right to Buy)F5$108.49holding————Aug 7, 2022Common Stock12,50012,500D
Stock Option (Right to Buy)F2$108.49holding————Aug 7, 2022Common Stock9,3759,375D
Stock Option (Right to Buy)F6$94.35holding————Aug 12, 2021Common Stock15,00015,000D
Stock Options (Right to buy)F7$106.59holding————Aug 18, 2023Common Stock18,81918,819D
Stock Options (Right to buy)F4$106.59holding————Aug 18, 2023Common Stock14,11414,114D

Explanation of responses